According to InnovAge's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.818264. At the end of 2023 the company had a P/S ratio of 1.13.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.13 | -19.95% |
2022 | 1.41 | 41.04% |
2021 | 1.00 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Merck MRK | 5.55 | 578.35% | ๐บ๐ธ USA |
Cocrystal Pharma
COCP | N/A | N/A | ๐บ๐ธ USA |
AcelRx Pharmaceuticals
ACRX | 22.4 | 2,636.86% | ๐บ๐ธ USA |
Horizon Therapeutics
HZNP | 7.31 | 793.07% | ๐ฎ๐ช Ireland |